久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.

BEIJING
Recommended Products
Categories
Contact Supplier
  • From:
  • To:
    BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)
  • Verification:
Company Profile
BEIJING
Acalabrutinib、Avatrombopag Maleate、Avapritinib、Daprodustat、Fezolinetant、Fruquintinib、Gefapixant citrate、Larotrectinib Sulfate、Mirogabalin Besylate、Niraparib Tosylate Monohydrate、Omarigliptin、Roxadustat、Resmetirom、 Sparsentan、Selpercatinib、Tofacitinib Citrate、Tirzepatide、Upadacitinib Hemihydrate、Vandetanib、Zuranolone and so on; 1-Bromodibenzo[b,d]furan、Dibenzo[b,d]furan-1-ylboronic acid、1-Dibenzofuranamine、1-(3-Bromophenyl)dibenzo[b,d]furan、2,4-Dichloro-6-(1-dibenzofuranyl)-1,3,5-triazine、2-Chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine、3-Bromobenzo(b)naphtho(2,3-d)furan、2-Bromoindolo[3,2,1-jk]carbazole、5-Bromoindolo[3,2,1-jk]carbazole、2-Bromobenzo[9,10]phenanthrene、2-Chloro-4,6-diphenyl-1,3,5-triazine、2,3,5,6-Tetrafluoro-7,7,8,8-tetracyanoquinodimethane,F4-TCNQ and so on
more >

Year of Establishment:

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages:

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service